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Quorum sensing  (QS) is a process that allows bacteria to communicate with each 
other to coordinate collective behavior in response to changes in environmental 
conditions. Their ability to mediate biofilm formation of biofilms and antibiotic 
resistance has created challenges on healthcare systems, and an impetus for us to 
understand QS systems. QS mediated by autoinducer-2 is likely to be the most common 
of these mechanisms. Recent work has elaborated on the LuxS-regulated (Lsr) system 
which can mediate and process AI-2 to QS-dependent behaviors, particularly regulatory 
elements including the lsr intergenic region and the repressor LsrR, the so-called QS 
“switch”. In this thesis, we present a simulation of an example lsr-QS-system to elucidate 
the role of the lsr intergenic region binding site interactions and how this model 
integrates with recent literature on LsrR’s protein structure to provide further details on 
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Chapter 1: Introduction 
Bacterial biofilms have become a significant public health problem that have 
not only increased the cost of medical care by contaminating devices, but have been a 
significant means by which bacteria propagate antibiotic resistance.  [1-4] The issue 
impacts many fields including implanted biomedical devices that become 
contaminated, such as prosthetic biomedical devices [1], include catheters[5-7], 
pacemakers[8,9], hip implants [1,10], and bone cement [11]. In urinary catheters 
alone, the development of urinary tract infections (UTIs) within catheters, and the 
resistance of bacteria to normal antibiotics have contributed to $400 million (USD) in 
additional costs to utilize such devices alone, and have resulted in up to 1 million new 
cases of hospital transmitted infections annually[7]. There are several strategies that 
have been used to mitigate these infections. One strategy has been to simply swap the 
infected device with  a replacement device. This presents a number of complications 
and increases the cost of those devices. Another strategy has been to treat the 
infections with antibiotics [7,12], or coat the devices with the antibiotic laden 
coatings or films [13-16]. While many trials have been performed, few had  any 
impact on reducing infections owing to the complex dynamic of infection processes, 
particularly those that gain multiple antibiotic resistance. (We discuss some 
mechanisms of multiple antibiotic resistance later in this section.)Few trials have been 
carried out carried out on complex biofilms containing multiple species of bacteria. 
Those that have reported some reduction in biofilm size, retain the possibility of 
increased antibiotic resistance ormultiple antibiotic resistance in the surviving 




with biocompatible materials, may still occur because the innate and adaptive 
immune systems may not recognize the surface as ‘self’, and thus not be ‘checked’ 
for pathogens because the ‘sensing’ neutrophils and lymphocytes may not be able to 
access the surface [17] (as one mechanism for assessing what is considered “self” vs 
“non-self” or “foreign”).    
Antibiotic resistance does not just happen in cases of implantable biomedical 
devices, but has been occurring in increasing frequencies independent of those from 
implantable devices. For instance, in some hospital tests for E. coli infections, over 
90% of the bacteria identified were multi-drug resistant [18,19]. The increasing 
frequency of vancomycin-resistant Enterococchi  (VRE)[20-28], and multiple drug 
resistant (MDR) Staphlococcus aureus (MRSA)[29-38] infections raises the concern 
that much of the current stock of antibiotics may be rendered useless against common 
infections. (In most cases, vancomycin is regarded as the ‘antibiotic of last resort’, 
due its strength and side effects [39].) In these bacteria, antibiotic resistance can be 
mediated through physical barriers that either keep bacteria without means to resist or 
utilize the antibiotic in a positive manner[4,40], or without efflux pumps to physically 
pump out the antibiotic once the antibiotic is recognized [2,41,42]. These efflux 
pumps and biofilm behaviors are described in great detail elsewhere. 
Nevertheless, the organization within those biofilms, and the ability of 
bacteria in biofilms to survive antibiotic treatment suggest that if bacterial colonies 
can be localized such that they remain planktonic (not form a biofilm), there would be 
many possibilities for improvement towards solutions that can not only prevent 




in treating infections. For that to happen, there needs to be some sort of central 
linking behavior that may cause bacterial colonies in one condition to remain 
planktonic, and for bacteria to form biofilms in another. This link can be based on 
nutrient availability, tensile or shear stress in the system, or on other stresses. Most 
importantly, this link is based on number density—how many bacterial cells are in a 
given area at a certain time. When bacteria would perceive this number density to be 
higher than a threshold exists, or a “quorum”—meaning that there may be too many 
members in an area to share resources and remain planktonic— so they may form a 
biofilm, or become virulent, or otherwise coordinate their behavior as a collective 
unit, taking on phenotypes that aid in determining their fate. Examples of collective 
behaviors that are regulated by quorum sensing are the establishment of biofilms, the 
attachment of pathogenic E. coli to epithelial cells, the transference of virulence 
factors, etc. Excellent reviews have appeared that explain the mechanisms of the 
signal transduction processes as well as additional examples of the emergent 
behaviors [43-52] [53] (UK). Briefly, these bacteria synthesize molecules dedicated 
to quorum sensing (quorum sensing molecules). When the concentration of these 
molecules is above threshold, and depending on external conditions, the quorum 
sensing molecule can be imported, processed, and induce the expression of genes that 
contribute to the formation of a biofilm, to virulence, to other behaviors including the 
facilitation of chemotaxis[54].  
Quorum sensing (QS) molecules can be classified into three different 
categories—N-acylhomoserine lactones (AHLs) including autoinducer-1s (AI-1s) that 




autoinducer-3 (AI-3) that may mediate both interspecies and intraspecies quorum 
sensing. Of these, AI-2 is the most ubiquitous, and most utilized of the known QS 
molecules[55]. Because of its detection among many species, and because many 
species contain a conserved pathway which produces AI-2 (which will be described 
in later sections), AI-2 producing and sensing systems have drawn significant interest.  
Based on their availability, and their application to a common class of MDR 
infections, we utilize the Escherichia coli (E. coli) QS system, and in particular, the 
E. coli K12 LuxS-regulated (Lsr) quorum sensing system as our system of interest. 
The current understanding of this circuit was described in Hooshangi and Bentley, 
and Tsao et al [56-58], and will be explained in more detail in later sections. 
Recently, however, our laboratory has undertaken a systematic study of the 
mechanisms of the transcriptional control circuits for this system. Byrd has developed 
new insight on the effects of the lone repressor in this system, LsrR, on gene 
expression in the bicistronic lsr regulon[59]. Influencing the interactions between 
LsrR and the lsr regulon have become a major starting point for the development of 
QS inhibitors, although initial studies have only targeted the prevention of the 
derepression of the lsr regulon [44,60,61], or efflux pumps that may pump out 
antibioitics. [62] Importantly Byrd demonstrated through genetic mutation of the 
intergenic region within the lsr regulon (between lsrRK and lsrA) that there are 
putative binding sites for CRP and LsrR that when considered in more detail reveal 
the possible existence of dimer and tetrameric forms of LsrR that play a role in the 




This thesis builds on the concepts of Hooshangi and Bentley [43] , but adds 
significantly more complexity to the regulatory cascade; the desire being to strike a 
mathematical representation of the results of Byrd. The thesis is organized into 
component parts: a section on Model Development; a section on Simulation Results; 
a section on Concluding Remarks; and finally, a section on Future Work that might 










Chapter 2: Model Development 
 
Previous work by Hooshangi and Bentley [43] demonstrated that we could 
build a simple deterministic model of the lsr AI-2 quorum sensing regulatory 
network, based on knockout experiments of regulatory components.  However, more 
recent studies have revealed more mechanistic detail of the transcriptional regulation 
and secondary regulators to the quorum sensing response. Therefore, we have 
reevaluated Hooshangi and Bentley’s model and significantly modified the model to 
improve its relevancy to a more sophisticated model experimental system. 
In order to develop our model, we needed to make some basic assumptions. 




Section 1: Assumptions in the Model 
Assumption 0: We have developed an idealized time-dependent profile for the 
appearance and disappearance of AI-2 that follows typical batch experiments of wild-
type E. coli K12 strains[63,64]. We consider this profile as a fixed profile that the 
model dynamics will be built around. 
 
Assumption 1: The model cell contains a mutation in the gene sequence of lsrB, 
meaning the transporter Lsr can be inserted into the plasma membrane of our model 
E. coli cell, but it cannot import AI-2. Likewise, this cell contains the ∆pts mutation, 
which knocks out the PTS pathway that is considered to be an alternate pathway for 
AI-2 importation besides the one through Lsr[65-67], and lsrK (Lsr transporter). 
Therefore, all phosphorylation of AI-2 occurs via the pathway through LsrK, and all 
AI-2 is imported into our cell by simple diffusion. With simple diffusion governing 
the AI-2 import, intracellular AI-2 that has not been converted to phospho-AI2 (AI2-
P) is assumed to reach rapid equilibrium with extracellular AI-2 concentration. This 
equilibrium between intracellular and extracellular AI-2 exists at all times throughout 





Assumption 2: Lsr kinase (from lsrK), the enzyme which phosphorylates AI-2 when 
imported through either the main pathway or through simple diffusion, is permanently 
stable. We allow our cell to express lsrK normally prior to all our simulations, and 
knock out lsrK before the start of any simulation. Therefore, we assume that no lsrK 
is made, and that lsrK’s activity can be represented by a single maximum rate 
constant, klsrK. 
 
Assumption 3: The amount of ATP consumed by our system is negligible to that 
which is consumed by other cellular processes. Therefore, we assume ATP 





Section 2: Detailed Development 
For simplification, our model of the lsr quorum sensing in LuxS knockouts is 
divided into four modules, which are summarized by Figure 1. Briefly, AI-2 is 
imported into our model cell via the AI-2 Importation Module (if not through the 
so-called alternative pathway involving the phophoenolpyruvate (PEP) transferase 
system) and processed via AI-2 Binding/Processing Module, which produces AI2-P. 
This AI2-P triggers derepression of Quorum Sensing (QS) Response Module, 
which produces a number of outputs including activation of the AI-2 Importation 
Module and the AI-2 Binding/Processing Module, or repression of the Quorum 
Sensing Response Module. This Quorum Sensing Response Module is regulated 
by input from the cAMP/CRP Module.  These modules will be described in the next 
several sections, which include our descriptions of the equations that describe the 





Figure 1: Overview of our quorum sensing system as divided into its basic 
components. Arrows govern the flow of outputs to inputs. Arrowheads pointing 
into an icon represent inputs, while arrows pointing away from our module in 
question represent outputs of our system. Connections in red represent 
conditions, and output flow that is not included in our model. The assumptions 
we make in Section 1, as well as throughout this discussion, are implemented 
instead. 
 
Subsection 1: AI-2 Importation Module 
In order for AI-2 to have any influence inside the E. coli cell, it must be imported into 
the cell. Importation into bacterial cells can happen through either simple diffusion or 
through some receptor-mediated process. Evidence has been built up for the existence 
of two different AI-2 internalization pathways in Enteric bacteria. The first is through 
a receptor-mediated process mediated by Lsr, the transporter that is produced by the 
lsrACDB flank of the lsr operon. Lsr is a multimeric membrane protein complex with 




lsrD).  Crystallographic studies have suggested that Lsr functions similar to an ATP-
binding cassette protein [46], requiring ATP phosphorylation and dephosphorylation 
in order to shuttle AI-2 into the cell and recycle Lsr. This process is diagrammed in 
detail in Figure 2. Briefly, if environmental AI-2 is above a threshold concentration, it 
will initially bind to the LsrB domain of Lsr. Upon the phosphorylation of Lsr’s 
intracellular domains via ATP, Lsr undergoes a change in conformation, and shuttles 
and releases AI-2 inside the cell. Once AI-2 is inside the cell, Lsr is dephosphorylated 
and returns to the original state, to import more AI-2.  Through the production of Lsr, 
induction of the lsr operon (which we define as the Quorum Sensing Module), affects 
the rate at which AI-2 imported through Lsr.  
 
Figure 2: AI-2 importation pathway via the transporter Lsr. 
 
While Lsr was the first transporter identified, Pereira and colleagues (cite) 




produce Lsr, did not significantly reduce AI-2 internalization. While lsrACDB was 
considered to be a main transporter system, another transport system, knocking out 
the phosphoenolpyruvate transferase system (PTS), produced a much more significant 
drop in AI-2 internalization [66,67]. However, how exactly PTS interplays within 
Lsr-independent AI-2 import remains unclear, and does whether PTS is the main 
component through which initial AI-2 import. Until we know further details, we will 
assume a time-dependent profile of AI-2 which is observed outside the cell and is 
exactly mimicked by the intracellular domain. In essence, while we know it is not the 
case, our assumption is akin to rapid equilibrium of AI-2 and AI-2P outside and 
inside the cell membrane. It is this profile that initiates the quorum sensing regulatory 
structures at predetermined times. We can also force AI-2 importation (via Lsr) to 
happen via making a point mutation in lsrA and lsrC that renders Lsr unable to bind 
to the plasma membrane.   
In wild-type E. coli cells containing LuxS, once the LuxS produces the AI-2 
precursor (DPD) and this is converted to AI-2, it has been proposed that this AI-2 
leaves the cell through interactions with a secondary transporter protein known as 
YdgG (or TqsA) [68]. It remains unclear however, how YdgG operates to export AI-
2, or if YdgG is even significant for AI-2 export in E. coli. So, for simplicity, we 
assume that this process happens through simple and rapid diffusion; and we can 
effectively ‘knock out’ the gene producing YdgG, ydgG, or otherwise disregard its 





Because we have now assumed AI-2 diffusion can happen both in the forward 
and reverse direction, we now assume that there is an equilibrium state between 
intracellular and extracellular AI-2. Assuming this happens rapidly, Assumption 1 
holds true for our cell. Therefore, we will assume import always happens, and PTS 
acts as a secondary regulator that is always on. 
While our model cell is incapable of producing or exporting AI-2, we must 
acknowledge our cells can still be placed into a dynamic AI-2 environment. Luo and 
colleagues demonstrated such a real system could be set up [69]. So, we set up a 
virtual machine controlling AI-2 concentration in our virtual batch, such that we see 
how our system responds as extracellular (and intracellular) concentrations of AI-2 
increase to some peak and then decrease to near zero levels.   
To do this, we fitted a pseudo-Gaussian curve to AI-2 activity data observed 
by Liang Wang et al [63,64], with the small conversion, which we assume here as 
1µM AI-2 = 1600 activity units BB170, and parameters α, β, and γ, parameters that 
define the characteristics of our pseudo-Gaussian function. (We call it a pseudo-
Gaussian curve because we are not dealing with probability distributions. True 
Gaussian functions, as we define them, represent probability distributions whose 
areas under the curve must equal 1 by definition.) The values from our fit are listed in 
Table 1, and the fit when compared to Liang Wang’s data is shown in Figure 3. This 
continuous function can be differentiated over time and used directly as a dynamic 
model input that is later integrated simultaneously with all other state variables. 






Figure 3: AI-2 Curve Fitting AI-2 curve (solid red line) fitted to data from [63] 
with the conversion factor of 1600 AI-2 activity units/1 uM AI-2 (blue filled 
circles) 
That is, we can now differentiate our form for Ao(t), our autoinducer-2 
concentration profile, yielding a variable input into our lsr system to obtain our ODE 
equation for our autoinducer-2 concentration in (2) (or I in Supplementary Figure 1). 
       (2) 
 
 
Subsection 2: AI-2 Processing Module 
While many studies have correlated AI-2 to the expression of the lsr operon, 
and other lsr-dependent genes, we also know that AI-2 (in whatever form is 
recognized by the species of bacteria in question) cannot directly activate 
transcription of Lsr[70,71]. Genetic structural analysis of a gene downstream from 




bacterial carbohydrate kinases—indicating that the new gene was likely a 
phosphatase. Because of its location within the operon, the new gene was dubbed 
lsrK, which produced the protein LsrK (luxS-regulated kinase).  Further experiments 
by Wang et al., 2005; Hooshangi and Bentley, Taga et al, and others which studied 
the effects of knocking out this new gene on transcription of the lsr operon 
[43,46,63,71] in E. coli and S. typhimurium suggested a strong correlation between 
knocking out lsrK and strongly reduced expression of Lsr, implying that LsrK 
converts AI-2 into an active form in order to de-repress the lsr operon. Taga et al, also 
performed ATPase assays on the new protein in vivo and demonstrated that lsrK had 
ATPase activity, and therefore LsrK was actually a kinase. 
A summary of our “AI-2 processing” module, as initially presented in this 
section, is diagrammed in Figure 3. Briefly, AI-2 that has been internalized into the 
cell binds to LsrK, and LsrK transfers a phosphate group from ATP (which also binds 
to lsrK) to AI-2, converting AI-2 to the active phosphorylated form, AI-2-P. Upon the 
release of AI-2-P, LsrK can take on another molecule of AI-2, and AI-2-P can follow 
on one of two paths---1) it can be simply degraded through a lsrG-dependent pathway 
initially identified by Marques  and colleagues [72] , or 2) it can activate the ‘quorum 





Figure 4: AI-2 processing module - steps involving lsrK and lsrG. 
Ordinary differential equations (ODEs) detailing components of the AI-2 processing 
module were derived from Figure 3, following the arrows in black (in general terms). 
These ODEs, including our ATP equation based in Assumptions 2 and 3, are detailed 
in equations II-IV in Supplementary Figure 1.  
 
Subsection 2.1: lsrG-Dependent Degradation of Phospho-AI2 
 While lsrG had been identified as one of the genes expressed when AI-2 de-
represses the lsr operon, its function had not been clearly identified until recently. In 
2007, Xavier and colleagues demonstrated that LsrG could convert AI-2-P to two 
polyglycolic acids. However, they observe that one polyglycolic acid (PGA) appears 
in larger amounts in vitro than does the other acid, suggesting that one PGA could be 
converted into another. So, Marques et al. created ∆lsrG E. coli mutants and tested the 




galactosidase reporter gene downstream from lsrACDB [72]. In the ∆lsrG strains, 
they find, through NMR studies, that AI-2-P accumulates intracellularly in levels 
close to tenfold higher than in cells containing lsrG. They also identified the two 
different PGAs that appeared in Xavier et al.’s 2007 study [70] as 3-hydroxy-2,4-
pentadione-5-phosphate (P-HPD) and 3,3,4-trihydroxy-2-pentanone-5-phosphate (P-
TPO) [72], an intermediate between AI-2-P and P-HPD known as 3,4-dihydropent-3-
en-2-ol-5-phosphate (P-DHPEO), and a final product from the non-enzymatic 
oxidation of P-TPO, which is 3,3,4,4-tetrahydroxy-2-pentanone-5-phosphate (P-
TetraPO). Jt is still unclear what happens with P-TetraPO [72], and so for modeling 
purposes, we simply assume that the modeling pathway is a degradation pathway that 
can be summarized by a single degradation rate constant kdeg_Ap, which is defined in 
Supplementary Figure 3.  
 
Subsection 3: Quorum Sensing Module 
Once LsrK phosphorylates imported AI-2 to form AI-2-P, it enters into our 
Quorum Sensing Module, , which can be summarized by Figure 4 and divided into 
several steps that include 1) cleavage of the LsrR tetramer, 2) the subsequent 





Figure 5: Diagram of the quorum sensing module. Binding of AI-2-P (red 
diamonds) to the lsrR tetramer (blue circles, bound to binding sites marked by a 
salmon-color) lead to the splitting apart of the tetramer into two dimers and the 
eventual cleavage of the AI-2-P lsrR dimers off of the lsr operon, partially 
derepressing the lsr operon. Binding of cAMP-CRP (yellow star with yellow ‘pac-
man’) to the CRP-binding sites (yellow on lsr operon) as a result of events in the 
cAMP-CRP module result in the full activation of transcription of the lsr operon, 
which produces mRNA for genes on both flanks of the lsr operon, as well as mRNA 
for the reporter (lacZ) associated with either lsrRK or lsrACDB. The mRNA is then 
translated into lsrR monomer (blue circles), Lsr (green pac-man), and beta-
galactosidase (teal hexagons). If LsrK is functional, expression of lsrK would feed 
back to the AI-2 processing module (red arrow). If LsrACDB is function, expression 
of lsr would facilitate more imporation of AI-2. lsrR dimerizes to form the free dimer 
(two circles), then binds to its binding sites on the lsr operon. The two bound dimers 






 Subsection 3.1: LsrR Tetramer Cleavage 
 The first step of the quorum sensing process involves the binding of AI-2-P 
(phospho-AI2) to LsrR. Experimental studies suggested that, based on genetic 
homology to similar proteins and preliminary crystallography studies [73], that LsrR 
exists as a tetramer when bound to four ‘operator’ (O) binding sites (putative binding 
half-sites) identify by Byrd as shown in Figure 6. We propose that the cleavage 
occurs as a two-step process. First, two AI-2-P molecules bind to the tetramer, 
cleaving the tetramer into two LsrR dimer-AI-2-P complexes still bound to their 
binding sites. Then, due to the instability of the LsrR dimer-AI-2-P-DNA complexes, 
the LsrR dimer-AI-2-P complexes are subsequently released from the putative 






Figure 6: The lsr operon containing the lsrR tetramer. (The LsrR tetramer consists 
of the blue circles bound joined together). The lsrR tetramer is bound to the operon at 
binding sites O1, O2, O3, and O4 (salmon rectangles). Removal of lsrR triggers the 
expression of lsrACDB (bottom, in green) or lsrRK (top, in green), and their 
associated reporters (signified by R, in light blue). cAMP-CRP complexes can 
enhance and fully activate expression of the lsr operon by binding to CRP-binding 
sites C1 and C2 (yellow).  
 These steps occur given a few premises. First, we assume that since the 
tetramer itself is formed by the binding of two homodimers, there have to be two 
binding sites on the homodimers (one on each homodimer) required to break apart the 
tetramer into two LsrR dimer-AI-2-P complexes removed from the lsr operon or else, 
we assume, we may still see complete repression of either flank of the lsr operon. The 
particular flank that would still be repressed would be the flank whose dimer is not 
bound to AI-2-P. We also assume that changes in the intermolecular forces, whether 
hydrophobic, steric, or electrostatic, between the dimer-AI-2-P complexes and their 
associated DNA molecules are strong enough to forces the complexes off of their 




pathway in which neither LsrR dimer nor AI-2-P are recycled back into the regulatory 
circuit. 
 Given these assumptions, we now identify our governing rate constants and 
state variables that are used in our model. The initial binding reaction of AI-2-P with 
the tetramer that forms the LsrR dimer-AI-2-P complexes bound to the lsr operon are 
governed by the rate constant kbind (see Supplementary Figure 4), and the cleavage 
reactions of the dimer-AI-2-phosphate complexes off of the associated dimer binding 
sites are governed by kcleave1 (lsrRK) and kcleave2 (lsrACDB). Bulk (LsrR) tetramer, AI-
2-P, (LsrR) dimer/lsrRK complex, dimer/AI-2-P/lsrACDB complex, dimer/AI-2-P 
complex, free lsrRK and free lsrACDB  concentrations are represented by the state 
variables (listed in Supplementary Figure 3) Tb, Ap (from the AI-2 Processing 
Module), Dp_b|lsrR, Dp_b|lsrA, Dp, lsrR, and lsrA respectively. 
Subsection 3.2: lsr Expression and Output 
Once LsrR has been released from its binding sites near lsrRK (∆lsrK) and 
lsrACDB, one would presume that expression of lsrR is straight forward—lsrACDB, 
lsrR and their associated reporters are transcribed (mRNA encoding each is 
produced), and translated into proteins (and an output for the β-galactosidase activity 
assay) including the monomer form of lsrR, and the transporter. We initially assume 
the transcription equations have the form shown in equation 18, for only the lsrACDB 
flank (transcribing monomer), where lsrA is previously defined. We introduce a 
constant, B, that represents the observed bias towards lsrR with the conditions held in 
19. Maximum rate constant, ktcR is the basal transcription rate for lsrR, kdeg_mRNA is 




our system are known and that lsr expression is not biased to either flank, for the 
purposes of our discussion.  
    (18) 
   
 (19) 
However, establishing unregulated transcription and translation after an initial 
activation event is a dangerous concept in modeling of biological systems. Several 
studies have suggested that cyclic-AMP (cAMP) acts as such a regulator through 
interactions with its receptor protein (cAMP receptor protein, or CRP)[74,75], which 
can, in turn, positively regulate expression of a target gene by improving the access of 
RNA polymerases and transcription regulatory proteins to the target sequence. In our 
particular case, cAMP-CRP binding to a DNA region upstream of either flank of the 
lsr operon could positively regulate expression of the lsr operon. While the DNA 
binding sections were identified as being upstream of lsrACDB and lsrRK, little was 
known about the role of the binding site sequences themselves because studies 
examining the role of cAMP-CRP binding in lsr regulation only addressed the role of 
the production of CRP. Then, Wang et al., positively demonstrated the binding of 
CRP to the operator regions within the intergenic lsr regulatory region [64]. 
Sequencing work by Byrd [59,76] identified the exact sequences for the two CRP 
binding sites in the lsr operon, labeled as C1 and C2 in Figure 5. This work also 
allowed him to directly introduce mutations into either CRP binding site (or both), 
and identify the role that the binding site sequence could play in mediating the 
regulation of the expression of lsr. When a point mutation was introduced at either 




(as measured by the β-galactosidase activity associated with a reporter lacZ attached 
immediately downstream of either lsrRK or lsrACDB) is reduced by 96% from the 
wild type population (E. coli containing intergenic plasmids containing unmutated C1 
and C2 sections), which provided an effect that was slightly stronger than was 
knocking out CRP. Therefore, we must take into account the ability of CRP, in 
particular cAMP-CRP complexes to bind to its binding site, as an effector of lsr 
mRNA synthesis. (We will detail the modeling of this particular process in section 
B.4, when we discuss the cAMP module.)  
The positive regulation we see with cAMP-CRP on transcription of the lsr 
operon is similar to those that have been modeled for β-galactosidase production in 
low-glucose conditions [75], as shown in equation 20. We will call this modifier Ω, 
and define it in terms of cAMP:CRP:C2 (cAMP-CRP complexes bound to site C2) 
and C2 (free C2 sites), and incorporate it as a multiplier before 18 to our next form of 
transcription as shown in equation 22. Increasing Ω increases the transcription rate of 
our transporter (and associated reporter). We will test our assumption of this form of 
Ω against the form of Ω, which we call Ω* in (21) which is part of the modifications 
we make to our model to determine whether our assumption will hold, later in this 
study when we modify the base model. 
        
 (20) 








We must now consider the possibility of transcriptional bias in our system. 
Transcriptional bias can arise in a biological system when a derepression event 
induces expression of genes both upstream and downstream of the repression sites. 
While expression or promoter bias appears to be common among eukaryotes, 
particularly higher order eukaryotes, Byrd was the first to demonstrate that this 
expression bias existed in E. coli, within its lsr operon. He demonstrated that the lsr 
operon is biased towards expressing genes on the lsrACDB flank of the operon—
through both ChIP-chip mircroassays and through beta galactosidase activity 
assays[59]. Based on this data, we know that B > 1. Later in this study, we will use 
his beta galactosidase activity data [59] to fit our transcription rate constants and 
determine the exact value of this bias. This bias, integrated into 22, along with the 
definition of ktcA in (23), allows us to complete our ODE for transcription (XII and 
XIV, for reporter mRNA).  
      (23) 
For now, however, we must continue our discussion lsr operon expression 
with a discussion of protein production and how we will measure our outputs. 
Because the bias of the lsrR system is in the direction of lsrACDB, we automatically 
set B, for the case of lsrR, to 1. Therefore, in the case of lsrR (variables mRNA|lsrR 
and mRNA|X) become equations XI and XIII, respectively.    
Ultimately, the product of the de-repression of the lsrR operon is the 
production of proteins on either side of the intergenic region of the lsr operon. Like 
transcription, the level of detail to which we will model translation (and the output of 
such) will depend on how much detail we actually need. Since we are not concerned 




translation simply happens—and that outside of the mutations that we have made in 
lsrACDB and knockouts of lsrK, all proteins (or monomers) are produced normally. 
(Had we not knocked down both genes, we would observe an increase in AI-2 
phosphorylation due to the additional synthesis of lsrK shown in Figure 4.) Second, 
we assume that when lsrA, lsrC, lsrD, and lsrB—the component proteins of the AI-2 
transporter, Lsr, rapidly polymerize into their final form and are translocated to the 
plasma membrane as such. We take this as an assumption since no evidence has been 
developed, nor mechanism has been proposed for the translocation of Lsr from the 
bacterial cytoplasm to the plasma membranes, cell walls, or capsules. Therefore, we 
can assume that translation of the transporter, lsrACDB, can be governed by a single 
translation rate constant, ktlA, and set Equation XVII to reflect our assumptions 
(assuming some degradation of the transporter).  
In addition to translation of LsrACDB, we must also consider the translation 
of lsrR, which is not as straightforward as that of the transporter because LsrR exists 
in active form as either a dimer or a tetramer, as shown by Byrd and Xiu. LsrR is 
most active in its repressor role as a tetramer. Because LsrR is polymeric (and a 
homo-polymer), further steps must be taken in order to form the fully active protein. 
These steps will be discussed in detail in Section B.3.3. 
Regardless of the functionality of our system, if we want to make our model 
reflect experimental reality, we must provide some output of the model that is readily 
understandable by experimentalists. Most microbiological experiments dealing with 
quorum sensing use some quantification of a change in intensity of a visual signal, 




commonly used to measure bacterial gene expression. So, if the output of protein 
expression can be tied to a change in the output of one of those assays, further 
experimentation can be used to help refine the model to meet the needs of 
experimental research. Because the beta-galactosidase activity assay is utilized more 
widely, we tailor our output to that. Details of this process are discussed in the 
Supplementary Text (Section S2). Equations XIII and XIV,  as previously discussed, 
describe the transcription of the reporter mRNA for either flank. Equations XV and 
XVI, which describe the beta-galactosidase activity in terms of bulk concentration 
rather than Miller Units, are identical to XVII and XVIII in form, with the exception 
that the functional unit, as converted in Supplemental Text S2, is converted to Miller 
Units (the standard activity unity in the beta-galactosidase activity assay), and that 
beta-galactosidase is assumed to degrade at a different rate than will either the lsrR 





Subsection 3.3: lsr Operon Repression 
 In order for the system to return to the original, state, the tetramer must be 
reformed. Here, we predict several steps based on homology to UlaR [59,77], and 
assumptions from previous models. First, LsrR monomer dimerizes to form the LsrR 
dimer (completing equation XVIII), and confirmed experimentally by Byrd and Lu, 
[59,77]. Free dimers then bind to the DNA at sites O1 and O2, or O3 and O4, 
effectively removing the lsrRK or lsrACDB available for transcription. In this model, 
we assume this DNA binding event occurs cooperatively with respect to our dimer. 
This assumption holds for any interaction between DNA and DNA-binding proteins, 
but we elect to only model the dimer binding step as such because cAMP-CRP 
binding only functions in a regulatory role. Derivations of the cooperative binding 
terms in equations XIX-XXI  are discussed in Supplemental Text S1.  
Once both dimers have bound to the lsr operon, we will assume at this point 
that there is a process, either through undiscovered assistive regulatory processes, or 
spontaneously, that the lsr operon closes back up and reforms the tetramer. This 
process is not cooperative, and is governed by the rate constant ktet. Once the tetramer 
reforms, our system returns to the original state. Since we track varying bound states 
of the dimer, and of the availability of free lsr operon, we are able to monitor the 





Subsection 4:  cAMP-CRP Module 
Cyclic AMP (cAMP), a regulator which highly influences the synthesis of the 
lac operon, is an important secondary regulator within the AI-2 quorum sensing 
process. Several studies have suggested that knocking out the gene producing cAMP 
producing protein, glycerol-3-phosphate (G3P) dehydrogenase [59,78], prevents the 
expression of genes on either side of the lsr operon.  Further studies suggested that 
cAMP caused these effects through interactions between its receptor protein, which 
we will call cAMP receptor protein (CRP), and genomic binding sites near the 
promoter sequences on either flank of the lsr operon, which we will call C1 and C2 
(see Figure 5 for location). It has also been demonstrated, through knocking out either 
CRP-binding site, that the production of lsrRK gene products requires the binding of 
the cAMP-CRP complex to C1 , and the production of lsrACDBFG similarly requires 
the binding of cAMP-CRP to C2[59].  In our model, we assume these binding events 
occur independently of the AI-2-dependent events.  These binding events are shown 
in the diagram in Figure 7, and the equations governing these events are described by 
equations XXII-XXVIII in Supplementary Figure 1, which are derived based on the 





Figure 7: The cAMP-CRP module. Cyclic AMP, assumed to already be present in 
the bacterial cell, binds with the cAMP-receptor protein (CRP) in the cytosol. The 
cAMP-CRP complexes then bind the lsr operon at site C1 (or C2). This binding event 
triggers transcription of genes bidirectionally on the lsr operon. cAMP-CRP is then 
cleaved off to reform the constituent cAMP and CRP molecules. 
In the case of this model, we assume a mechanism that involves cAMP-CRP 
binding together in the cytosol before binding to the CRP binding site shown above. 
However, CRP bound to C1 without cAMP bound to CRP’s ligand-binding domain 
(LBD) can still bind to site C1. In this case, bound CRP is thought to help with the 
folding of the lsr operon and help re-form the LsrR tetramer, but further studies (yet 
to be published) suggest that there may be more interactions involved than previously 
identified. And so, we leave studying the effects of mutations of CRP sites to our 
future work. And for this study, we simply assume the mechanism above for the 





Subsection 5: Synthesis Module 
In order for AI-2 to exist in real cell media, it must be synthesized somewhere. 
The pathway for AI-2 synthesis has been well-established in E. coli and appears to be 
conserved among many bacterial species. We discuss the pathway here, but we do not 
incorporate AI-2 synthesis into our model as a part of this work. Rather we will 
incorporate the AI-2 synthetic pathway in a future extension of our model.  
The main pathway is relatively simple. Methionines are converted to S-
adensosylmethionine (SAM) by the enzyme MetK. This is followed by the 
demethylation of SAM by the enzyme CheR (in the presence of a methyl acceptor) to 
form S-adenylhomocysteine (SAH). SAH is then hydrolyzed by the enzyme Pfs to 
form S-ribohomocysteine (SRH). The enzyme LuxS, knocked out in our study, then 
converts SRH to an AI-2 precursor known as 4,5-dihydroxy-2,3-pentanedione (DPD), 
which is unstable and immediately converted into one of several more stable isomers 
which are known as AI-2.   
Each step in this process is regulated by a number of means. At the SAM to 
SAH step, the enzyme SpeD can compete with CheR (or a similar SAM-
demethyltransferase) for SAM. Instead of SAM being converted to SAH, SAM could 
be decarboxylated and converted to the alternative product MTR, as well as 
spermidine and adenine[79]. At the SAH to SRH step, cAMP can upregulate this step 
by increasing the synthesis (and thus availability) of Pfs[63,79,80]. Conversely, 
because cAMP is often synthesized as a signaling molecule in E. coli in low-glucose 
conditions, this conversion of SAH to SRH is downregulated in the presence of high 




carry out opposite effects based on increasing or decreasing the expression (and 
production) of LuxS—except in that LuxS expression is positively correlated to 
glucose concentration (rather than to cAMP, as with Pfs expression). 
Even in conditions that are supposed to mean high optimal AI-2 synthesis 
inside the cell, depleting the cells of iron(III) ions (or LuxS in cell-free media of 
iron(III) ions), depletes the concentrations of AI-2 that are synthesized. [81] 
Therefore, it is implied that iron(III) ions activate LuxS by binding to some regulatory 






Section 3: Model Implementation and Calibration 
Subsection 1: Calibration of Transcription Constants ktcR and B 
One of the main goals of the model we are developing is to explain and 
simulate experimental data. And in order for our model to be supported by  
experimental data, we must be able to fit our parameters to some sort of real data. In 
the absence of methods to test a lot of our kinetic parameters, we utilize output 
features from previously published data (Byrd, 2011). Since the only temporal 
domain data we find refers to the expression of lsrRK and lsrACDB in Miller Units, 
we must calibrate our model accordingly. For all intensive purposes, we assume that 
translation is governed by the rate constants ktl and ktlA, which are each set to 1 min-1. 
So, we utilize the output data to determine our transcription rate constants ktcR and B.  
To determine ktcR, we first assigned a starting value of ktcR = 0.1 min-1 and B = 
1 (assuming zero transcriptional bias in our system). We then implemented our ODE 
system with ktcR varying from our preliminary value of 0.1 min-1 to 1 min-1. Then, we 
extracted our data points that matched the time points from Byrd’s activity unit data. 
Due to the adaptive step-size utilized by MATLAB in order to compute the numeric 
integral, an exact match between the time point in Byrd’s work [59] (approximated 
and reproduced in Figure 8) and that in the data point may not be found. So to 
compensate, we find the time point in our model simulation that is closest to the 
particular time points in the data (with the least amount of error). We then find our 




integrated (See Section B.6.2. for how it was implemented), and compile them into a 
row vector the same length as our experimental time vector.  
Once we have these data points, we selected our ktcR by calculating R2 values 
between the model with the ktcR in question. R2 is a statistical measurement which 
determines how well data fits to a particular model, or how well a particular model 
fits to a known set of data. We define R2 as a metric to test the latter, and we calculate 
it via the calculations in (24) through (26). 
We start our calculation by defining our vector of β-galactosidase activity data 
(without considering which flank we are considering right now) , and the predicted 
β-Galactosidase activity data from our model at a particular ktcR, Y.  We can now 
define our error vector, ε with a length L (also equal to the length of the time vector 
from the Byrd data), by vector equation in 24. (These errors can also be called 
residuals.) 
       (24) 
In the first step to normalizing the error, we find the sum of the square of the 
error, SSE, as shown in (25), for our error vector ε by squaring each element (εi) and 
adding the elements together.        
 
In order to compare this error with the variance within our data, we now 
compute the total sum of squares of our data in , SStotal as shown in (26), where 
Var( ) is the variance of  





We now can compute R2 as shown in (27). 
 
We note a few key observations. If SSE > SStotal, we observe that our R2 value 
will be negative, meaning that we cannot use our model to predict our data. Thus, we 
reject ktcR values that produce an R2 < 0. Likewise, if SSE = SStotal, we will have an 
R2 = 0, which represents random correlation. Because of this, we also reject any ktcR 
which results in R2 = 0. Therefore, the first class of ktcR values we accept are those 
with R2 > 0. Because of our definition of R2 (and that SSE and SStotal cannot be 
negative), the maximum R2 we obtain would be R2 = 1, which defines a perfect fit to 
our data. Because of this, we select our ktcR based on which ktcR produces the highest 
R2 value, when compared to our data.  
After the initial round of implementing this algorithm and rejecting the 
negative R2 values, we identify the ktcR values such that R2 went from increasing to 
decreasing, and used those ktcR values to refine our estimate for ktcR. When we could 
not improve our R2 value any further, we selected the ktcR that produced the highest 
R2 value.  
After selecting a ktcR value, we hold ktcR and vary our transcriptional bias B 
over a pre-defined range, and select our B using a similar protocol to the one we just 
described for selecting ktcR, except utilizing the ktcR we had previously estimated.   
As we will demonstrate in Section 3.2.2 (Chapter 3, Section 2, Subsection 2), 
this approach will form the basis of how we might utilize our model to demonstrate 





Subsection 2: General Model Implementation  
In order to solve our model, we needed to select a program that could 
integrate our model in an accurate, yet computationally efficient manner. To do this, 
the models were implemented using the constants in Table 1, the initial values in 
Table 2, and in MATLAB (Mathworks, Inc.) and integrated using MATLAB’s 
ODE23s algorithm. (ODE23s is one of many ODE numerical integration algorithms 
that comes prepackaged within the MATLAB software package, which uses a low-
order (n=1) Runge-Kutta method which is capable of handling stiff systems. Higher-
order non-stiff algorithms may have provided a higher-accuracy solution by running a 
higher-order Runge-Kutta integration step, we found that these higher-order nonstiff 
methods, with regards to integrating our 28-equation ODE system, too 
computationally expensive to be integrated on a standard 64-bit personal computer.) 
 
Subsection 3: Implementation of Sensitivity Analysis 
Sensitivity analyses are useful tools to understand how a system would change 
in response to the changing biological conditions of a system, or what would happen 
to our system under differing conditions for rate constants. For linear systems, this 
process is relatively simple. We would first find all our equilibrium points (solving 
our mass matrix dYdt = 0, where Y represents then entirety of our ODE system as 
shown in Figure A). Then, we would find the Jacobian of that matrix and find the 
eigenvalues and/or eigenvectors of the resulting matrix. We could then plug in our 
equilibrium points to determine the stability of our system at those points. If the real 




stable at those conditions. If any eigenvalue is zero then we cannot determine the 
stability of the system at that point. If any eigenvalue has a positive real component, 
the system would be marginally stable at best (if every other eigenvalue is negative), 
and likely to be unstable. Discriminant analysis can be used to determine the ranges 
of each rate constant that could predict the behavior of the system. However, in large 
systems, discriminant analysis becomes complicated and computationally expensive.  
And for large nonlinear systems, no standard algorithm for determining 
stability points exists. Even if one existed, completing one for a 28-D system may be 
more computationally expensive than simply evaluating the ODE system over a 
period of time, simply changing one particular constant.  And so, we perform our 
sensitivity analyses by varying our rate constants within a range that we predefine. 
For our system, this may represent a certain fold increase or decrease in transcription 
rate of our gene, in dimerization rate of a protein, or affinity of a protein for DNA (in 
the form of dissociation constants). How this increase or decrease in each rate 
constant depends on how we define them to begin with. As we show in sections C.3. 
and C.4, modifying the value of a constant or form of transcription influence the 
behavior of our system, not just with the immediate effects, but with state variables 
that are further downstream. 
As to some applications of our sensitivity analysis, we might want to know 
what happens with expression of lsr if we reduced or amplified the affinity of the 
LsrR binding sites for LsrR, citing situations in which we might make a point 




track primary and secondary effects of changing the rate at which a regulatory or 
primary reaction process might happen.      
 




Chapter 3: Results 
 
Section 1: Fitting the Basic Model Shows a Dynamic Response to the External AI-2 
System 
Using the equations in Figure A and the constants in Tables 0 and 1, we 
created a base case for the model to determine how our control would respond over 
time.  
Figure 8 shows the general response curve of the AI-2 phosphorylation-
dependent equations as a response to our AI-2 and ATP input (a). As the intracellular 
(and extracellular) AI-2 concentration in our system increases, we see an increase in 
the production of both products including AI-2-P (shown in (c)), and ADP (shown in 
(b)). As AI-2 concentrations fall off, AI-2-P and ADP production stop and the 
concentration-dependent degradation of ADP and AI-2-Pstart to dominate. The peak 
in AI-2-P concentration occurs at t=400 minutes and has a full width half maximum 
(FWHM) of ~240 min, roughly the same time at which our fitted AI-2 concentration 
curve peaks but a larger FWHM. The FWHM of AI-2-P curve, is smaller than that for 
ADP (FWHM = 350 min) because AI-2-P, as has been well established, drives the 





Figure 8: Dynamics of  lsrK-dependint phosphorylation reactions. The dynamics for 
the lsrK-dependent phosphorylation of AI-2 is shown over a simulation period of 
1000 minutes. Our input ATP and AI-2 concentration profiles are shown in (a). The 
lsrK-catalyzed reaction between ATP and AI-2 produce the ADP (b) and AI-2-P (c) 
in the manner shown.  
 
Fittingly, as the plots in figures 9a-d suggest, the resulting AI-2-P dephosphorylation 
can be tied to decreases in tetramer concentration. When we examine tetramer 
concentration in the presence of AI-2, we observe that as AI-2 increases, our tetramer 
concentration decreases from our initial value of 20 molecules/cell (20 copies of the 
lsr intergenic region (as well as lsrR and lsrACDB)) to almost zero when AI-2 
concentration hits its peak, and rises again back towards the original state as AI-2 




phosphorylated lsrR dimer and free phosphorylated dimer concentration profiles 
follow the patterns we see for our AI-2-P and tetramer curves. When the free AI-2-P-
dimer complex appears, we also see a similar appearance in the free (de-repressed) 
lsrRK gene or free (de-repressed) lsrACDB gene in equal magnitude, as shown in 
Figure 10. The concentrations of those free genes increases with increasing AI-2 at 
roughly the same time point, and then decreases as AI-2 (and AI-2-P) become less 
available, and as synthesized dimer binds to the free genes.  
 
Figure 9: Tetramer cleavage reactions. The lsrR tetramer (b, in blue) is 
dephosphorylated in response to the input AI-2 and ATP, and subsequently AI-2-P 
concentrations in (a). When AI-2-P binds to the lsrR tetramer, it initially forms an 
immediate AI-2-P/lsrR dimer complex that is bound to binding sites O1 and O2 
(Dpb|lsrR), and O3 and O4 (Dpb|lsrA) in the lsr regulon as shown in (c) (scale: 1x10-6 




AI-2-P/lsrR dimer complexes (phosphorylated dimers) (d) break away from the 
aforementioned binding sites.  
When the lsrRK  and lsrACDB genes are transcribed (as well as the mRNA 
genes) they follow a similar profile to everything else. They increase to peaks at 
around t = 240 minutes and decrease back down to a steady state close to zero for the 
rest of the simulation (though the decrease does not really happen until after t=360 
minutes). The general profile of mRNA synthesis also translates to the production of 
Lsr, and the monomer form of LsrR, as expected. However, the relative profiles of 
beta galactosidase (check for beta galactosidase everywhere in the thesis to make sure 
it’s the same everywhere – hyphen no hyphen etc… activity in both lsrR and lsrA 
directions, as shown in Figure 12, follows more of a sigmoidal profile, reaching an 
equilibrium state when AI-2 is depleted, since we do not include a degradation term 
for beta galactosidase. Some modifications to the mRNA transcription terms are 
discussed in the sensitivity analysis in section C.3. We also consider the allosteric 
regulator cyclic AMP (cAMP) and its influence on expression of lsrR and lsrACDB. 
Furthermore, these similar observations extend to the synthesis of AI-2 transporter 
(Lsr), shown in Figure 11 and reflected in the beta-galactosidase activity data in 
Figure 12, since the transcription and translation of lacZ attached to either lsrR or 
lsrA is controlled by the same promoters controlling transcription and translation of 





Figure 10: lsr operon de-repression and LsrR monomer synthesis. The de-repression 
of lsrR and lsrA to free states (c) and the transcription (c) and translation of the lsrR 
mRNA to lsrR monomer (d) in response to AI-2-P input (a). Figure (b) shows the 
concentration of lsrR tetramer in our system, that its derepression by the binding of 
AI-2-P is tied to the increase in the rate of de-repression of lsrR and lsrA and the 






Figure 11:  Production of lsrR transporter in the model. Production of the lux-S 
regulated transporter Lsr from lsrACDB. AI-2 phosphorylation (a), besides activating 
the transcription and translation of lsrR monomer, also induces the production of 
mRNA transcripts of lsrACDB (c) which produces Lsr (d). Scale for mRNA 
concentration in (c) is 10-3 µM.  
This base model was fitted to Byrd’s transcription data up to t=10 hours (and 
ignoring the overnight culture) using an R2-based algorithm previously described in 
Section B.6.1.   The fit values for this “base case” are shown in Figure 13. These 
points, along with the transcription of the associated mRNA of the beta galactosidase 
genes associated with lsrR and lsrA, are shown in figure 12 (c) and (d), in 
correspondence to the variable AI-2 and AI-2-P input (a) and LsrR tetramer that 
represses our system. The beta galactosidase activities, unlike LsrR monomer and 




concentration). But, like in the monomer and transporter concentrations, they appear 
to start to reach an equilibrium level in the absence of AI-2 at t > 240 minutes. And 
so, in the base case, the fit to Byrd’s dynamic data with a wild type insert of plsrA14 
and plsrR26 (plasmids containing the wild type intergenic regions with lacZ reporters 
expressed in either the lsrA direction or the lsrR direction)..  
 
Figure 12: Beta-galactosidase activity associated with de-repression of the lsr 
operon. (a) shows the input AI-2 and resulting AI-2-P concentration profiles we fitted 
before. (b) shows the dynamic response of the lsrR tetramer concentration. (c) shows 
transcription of lacZ reporter genes attached upstream of either lsrR and lsrACDB 
(scale is 10-3 uM mRNA), and (d) shows the beta galactosidase activity that results 
from AI-2 activation in Miller Units. The points from Byrd (filled-in triangles) are 





FITTED PARAMETER VALUE R2 
ktcR 2.1 min-1 0.9321 
B 1.225 0.9250 
Figure 13: Estimated values of ktcR and B 
To close the loop on our system, the lsrR monomers dimerize to form free 
lsrR homodimers. The dynamics of this part of the loop are shown in Figure 14. LsrR 
monomer concentration follows a profile similar to that of the mRNA concentration 
profile for lsrR, in that it increases to a peak value, stays close to that peak value until 
AI-2 is partially depleted, and then decreases back to zero rapidly as AI-2 is further 
depleted. The free LsrR dimer concentration, on the other hand, appears to form a flat 
line until approximately t = 360 min, after which it starts increasing to an equilibrium 
value beyond the 10 hour simulation. This odd event is highlighted by the 
concentration profiles of LsrR dimers bound to the putative binding sites in figure 
14d (which follow each other). This observation suggests that the formation of the 
free LsrR dimer could be a rapid step until the putative binding sites reach saturation. 
The rapid increase (and eventual equilibration of) LsrR tetramer concentration 
confirms that the AI-2 depleted system reaches equilibrium. And by the end of the 
simulation, most of the available bound dimers have re-formed the initial 
concentration lsrR tetramer, corresponding to a near-zero concentration of AI-2. 
Several studies suggested that this simple folding of the tetramer does not happen 
simply from lsrR dimers binding to both sets of putative binding sites. Rather, it is 
believed that CRP, when bound to C1 and C2, may assist in the folding of the lsr 




lsrR tetramer. In Figure 15, we consider the cyclic AMP dynamics of our system. In 
our model, we assume CRP binding, or more specifically cAMP-CRP binding, to the 
CRP binding sites C1 and C2 in our system. All components of this system reach 
equilibrium with each other, suggesting that there will always be cAMP-CRP 
complexes that are bound to C1 or C2 (or both) at any point in the simulation. This 
may assist both the folding of the lsr intergenic region and the derepression of lsrR 
and lsrACDB. That is, we do not describe CRP dynamics in the current model. 
The dynamics of the CRP-related module (cAMP module) are shown in 
Figure 15, and suggest that the binding of cAMP-CRP complexes to CRP binding 
sites (as shown in figures 15c-d), as well as the formation of CRP complexes (15c) 
appears to be AI-2 independent (shown in 15a and b), as well as independent of the 
breaking apart of lsrR tetramer. However, figure 15e) suggests that while the actions 
appear to be independent, only a small concentration of CRP binding sites appear to 
be occupied despite excess cAMP and CRP present in our simulated sample. And so, 
we do not know enough from this base case to necessarily confirm the regulatory role 





Figure 14: Re-formation of the tetramer. Dynamics of the re-formation of the LsrR 
tetramer (b) in response to AI-2 and ATP, and consequently AI-2-P input (a). 
Increases in AI-2 lead to a significant decrease in lsrR tetramer, which leads to the 
synthesis of lsrR monomer (c). The monomers in (c) then form a homodimer (shown 
in c), which then bind to the putative binding sites O1/O2 (Db|lsrR) or O3/O4 
(Db|lsrA) (d). An increase in free LsrR dimer occurs at t=450 min due to the started 






Figure 15: Cyclic AMP regulatory dynamics. Cyclic AMP (cAMP) and CRP 
initially form cAMP-CRP complexes (c). This reaction, not being dependent on AI-2 
and ATP concentration (a) or tetramer concentration (b), moves to rapid equilibrium. 
(d) tracks the concentration of cAMP-CRP complexes bound to CRP binding sites C1 
and C2. (e) shows the dynamics associated with the free CRP binding sites (C1 and 








Section 2: Adjustments to the Model 
The basic model may be the first model of the lsr operon that takes into 
account the molecular dynamics of LsrR and its interactions with the operon. We 
reveal further dynamics of the model through a generalized sensitivity analysis of two 
different parameters Kbind|lsrR and Kbind|lsrA, and model specific effects of particular 
mutations of various binding sites through their effects on specific binding parameter. 
Kbind|lsrR and Kbind|lsrA are micro-dissociation constants that govern the binding of 
the LsrR dimer to either the O3/O4 half-sites (Kbind|lsrR) or O1/O2 half-sites. The 
lsrR or lsrACDB genes are considered repressed in one direction once the LsrR dimer 
binds to the set of half-sites in the direction of gene expression in which we are 
interested. (More  on this matter will be discussed in Section 3.2.2.) 
 
Subsection 1: Effects of Specific Mutations 
Previous studies by Byrd and others suggested that specific mutations to 
different genes within the lsr operon had differing effects in affecting the 
bidirectional expression of the lsr operon. To demonstrate such effects, we examined 
several such mutations—the lsrR knockout mutation, which we identify as CB11, and 
various binding site mutations—the putative binding sites O1, O2, O3, and O4, whose 
mutations we attempt to reflect by fitting Kbind|lsrR and Kbind|lsrA to the WT 
conditions. But before we begin discussing those results, we had to define our CB11 





Subsection 1.1: The lsrR Knockout (CB11 strain)  
As mentioned in the previous section, Byrd developed a strain of E. coli K12 
that were lsrR knockouts. In his experimental studies, he found that expression of 
lacZ reporter genes in either direction were significantly higher than in similar wild 
type strains (expressing lsrR normally). In our simulation, we reflected the CB11 
mutation by defining a new protein translation constant ktlM, which in the wild type 
case, is equivalent to ktl. In CB11, ktlM = 0. We also set Tb = 0, and lsrR = lsrA = 
N*0.00167 uM/(molc/cell) (calculated in Supplementary Text S2), where N is our 
copy number.  
 

















Figure 19: Bound dimer differentiation in wild type and lsrR knockout (CB11) 
conditions. 
As we expected, and as shown in Figures 17 through 19, we do not any 
significant concentration of LsrR products in the CB11 system. We see several 
features. First, mRNA concentrations in reporters and genes in both directions 
(including the garbage “knockout mRNA” reach a non-zero steady-state in the CB11 
case, rather than return to zero as they would in the wild type. This is consistent with 
permanent derepression of the lsr operon. Second, we observe that Lsr transporter 
concentration reaches a non-zero equilibrium state, in absence of LsrR-dependent 
repression. Third, and probably most significantly, we observe that beta-galactosidase 
activity moves from a sigmoidal profile that reaches a steady state to a linear profile 




algorithm, we find that we can fit that data best with ktcR = 3.25 min-1 (R2 = 0.8566) 
and B = 1.64 (R2 = 0.8849).  
 
Subsection 1.2: Reflecting Real Mutations in the Model   
 
One application of our model might be to examine the effects of particular 
mutations within the lsr intergenic region on the expression of our operon. As 
previously stated, our model is the first model to consider the molecular dynamics of 
the LsrR repressor, rather than simply a “quorum sensing switch” in the Lsr quorum 
sensing system. We previously suggested how theoretically how adjusting our micro-
dissociation binding constants could affect the expression of the lsr operon, raising 
expression levels in both directions.  
We test this assumption by simulating model systems in which plasmids 
containing mutations of different combinations of binding sites have been inserted 
into the genomes of E. coli K12 bacteria. A summary of the mutations is listed in 





Figure 20: Table of mutations studied in this thesis. Values in this data set are 














Description of plasmid (excluding promoter 
and lacZ reporter) 
Parameter 
estimated 




plsrA34 plsrR33 Contains mutations to putative binding sites 
O1 & O4 
Kbind|lsrR & 
Kbind|lsrA 
plsrA13 plsrR24 Contains mutations to putative binding sites 
O1 & O2 
Kbind|lsrR & 
Kbind|lsrA 
plsrA12 plsrR25 Contains mutations to putative binding sites 
O3 & O4 
Kbind|lsrR & 
Kbind|lsrA 
plsrA11b plsrR27 Contains mutations to putative binding sites 
O1 & O3 
Kbind|lsrR & 
Kbind|lsrA 
plsrA11 plsrR30 Contains mutations to putative binding sites 
O2 & O4 
Kbind|lsrR & 
Kbind|lsrA 
plsrA32 plsrR31 Contains mutations to putative binding sites 
O2 & O3 
Kbind|lsrR & 
Kbind|lsrA 








pcrp9 pcrp22 Contains a mutation to CRP binding site C1 kC1 & kC2 





When Byrd ran each mutation in CB11 and Wild Type E. coli K12 strains, he 
reported the expression in terms of Miller Units (as we have used for our model). 
However, in this experiment, these experiments were run as overnight culture 
(defined here as t = 10 hours) with only the final expression values being reported. 
We estimate what each mutation does in our system by first estimating our 
transcription constants—ktcR and B—such that the activity value in our simulation is 
within 0.1 Miller Units of the experimental value, with a shooting method algorithm 






















Briefly, we selected an initial range of ktcR, and integrated our CB11 model 
with ktcR in that range. Then, we extracted the t=600 point, calculated the beta-
galactosidase activity in the lsrR direction, and then calculated the error for each 
constant relative to the target value. If we were not already within our threshold of 0.1 
MU, we looked for a sign change in the error. We selected our new bounds at the sign 
change, and repeated these steps until we either found a ktcR within our error 
threshold, or we were approaching some asymptote in the minimum.  Having our ktcR, 
using the CB11 conditions again (since ktcR and B in this case represent transcription 










Figure 24: Binding and constants for each mutation experiment 
 
 
Figure 25. General algorithm used for each mutagenesis experiment. The general 
algorithm used to estimate each data point in Figures 22-24 as a series of subroutines 





Figure 26: Representative shooting-based algorithm used to estimate Kbind|lsrR and 
Kbind|lsrA in mutation experiments. 
 
In our studies of putative binding site mutations, once we had our ktcR and B 
for each case, switching to the wild type conditions, Kbind|lsrR and then Kbind|lsrA 
were estimated to our error thresholds, except for cases in italics using the algorithm 
in Figure 22. In those cases, Kbind|lsrR and Kbind|lsrA are estimated to a steady-state 
value. To compare what our activities represented in terms of repression, we 
calculated percent repression (%Rep) using equation 30, where  represents 




lsrX, we use lsrX to represent either the lsrR direction or the lsrA direction. 100% 
repression represents 0% expression relative to the lsrR knockout. 0% repression 
indicates that expression levels are very similar to those of the lsrR knockout.    
 (30) 
As shown in Figures 23-25, we are able to estimate Kbind|lsrR and Kbnd|lsrA 
when our system is more than 10% repressed. Under 10% repression, we are only 
able to hit the ‘steady state’ value. This ‘steady state’ value was determined by doing 
one iteration of the Kbind|lsrR/Kbind|lsrA algorithm (see Figure 25) varying Kbind|lsrR 
and Kbind|lsrA in the direction which reduces the magnitude of the error in beta-
galactosidase activity. These cases feature a mutation at putative binding sites O1, 
O4, or both. Byrd suggested that these mutations would have a much greater effect 
than mutations at sites O2 or O3, or both because of the mutations’ proximity to the 
promoter regions P1 and P2 in the lsr intergenic region. In his case, % repression was 
reduced to <5%. In our case, the O1/O4 mutation resulted in our lowest percent 
repressions, but no smaller than 9.8% repression in the lsrR direction and no smaller 
than 11% repression in the lsrA direction.  
Outside of those mutations, our estimation algorithms and our model are able to 
predict mutant behavior in the putative binding site regions. This model is the first 
ODE -based model to measure the effects of particular putative binding site mutations 
.  There also appears a dependence of the putative binding site constants on overall 
transcription of lsrRK and lsrACDB. Fittingly, in the wild type system, the more lsrR 
mRNA is produced, the more dimer is produced. Because the total amount of binding 
sites is limited by both our copy number N and our assumption that bacterial 




Therefore, the micro-dissociation constants governing these binding reactions will be 
larger. The larger micro-dissociation constants suggest that a higher concentration of 
LsrR dimer competition could make the repression step appear weaker. It also 
compounds a problem of the model as to what happens with excess LsrR dimer. Lu 
and colleagues found that each LsrR dimer had a distinct ligand-binding domain 
(LBD) at the C-terminus and a distinct DNA-binding domain at the N-terminus (the 
opposite end of the protein [73,77]. Although no work has been directly done to study 
the particular LBD of the LsrR dimers, proteases could recognize and bind to the 
LBD to degrade the excess dimer. Likewise, we could implement such a degradation 
model in Michaelis-Menten form, if the kinematics of the degradation reaction of a 
protease with the matching LBD is known or experimentally determined, or as 







Chapter 4: Preliminary Conclusions 
. In this study, we designed and tested a network ODE-based mathematical 
model of the dynamics of the lsr operon—the “quorum sensing switch” in the AI-2 
quorum sensing system in many bacteria. For the first time in E. coli, we were able to 
model the lsr operon in its quorum sensing role taking into account the molecular 
dynamics of LsrR as a tetramer. (Previous models had only considered LsrR as a 
single repressor, and did not take into account its dynamics, nor those of the lsr 
intergenic region. [43,82]) We also fitted this model to reflect dynamic expression on 
both sides of the lsr operon in response to a dynamic AI-2 profile. We also studied 
how our binding and transcription constants would change the expression of the 
operon in either the lsrR direction or the lsrA direction. The change in expression of 
genes in the operon, as we note later, may be a proxy for the 140 genes whose 
expression is altered by knocking down lsrR, and by our work and suggestions from 
the work by Ha and colleagues, changing the ability of LsrR to bind to its binding 
sites in the lsr intergenic region. Byrd inserted plasmids with expression vectors 
expressed in the lsrR direction and the lsrA direction containing several mutations of 





Figure 27: Single strand genetic sequence (with mutations in complement) of the lsr 
intergenic region. [59] 
The putative binding site O1 (sequence TGAACA) and putative binding site 
O3 (sequence TGAACA) are identical. The mutation performed to the complements 
of both binding sites (4: T->A) is also identical, changing a pyrmidine complement 
for a purine bonded by the same number of hydrogen bonds. Yet both have different 
effects. Mutating O1 in conjunction with O4 (TGTTCA: 4: AG & 5: GA) 
decreases %Rep significantly in both lsrR and lsrA directions, and significantly 
increases Kbind|lsrR and Kbind|lsrA. But the O1 mutation in any other context seems to 
be dependent on other mutations. Mutating the seemingly identical O3 site with the 
same mutation increases ktcR from the 0.9-1 min-1 to 3-5 min-1 range and decreases B 
from 1.222-1.4 to < 0.38, changing the transcription bias from slightly in the lsrA 
direction to significantly in the lsrR direction. The putative binding site constants 
(micro-dissociation constants) also increase significantly from a base value in the 10-5 




mutation in O3 may be more significant. It does not simply just pull the DNA base 
pairing too close for hydrogen bonds to form (and for the DNA) to be stable, but it 
also significantly decreases the interaction strength between the DBD of the LsrR 
dimer and O3. Wu and colleagues suggest that the LsrR ligans that might be a part of 
the DNA binding domain are Gln-33 (glutamine-33), and Tyr-26 (tyrosine-26). Given 
their codon sequences, it is more likely that the mutation affects the binding of Gln-
33 to the putative binding site, and that LsrR binds to O3 at the glutamine-receptive 
region. Changing the sequence may affect the protein’s ability to bind to that residue 
changing the steric forces between the mutant complement and the normal binding 
strand. But from Wu’s work and comparative studies with the sorbitol operon 
regulator SorC and the central glycolytic genes regulator (CggR) in Bacillus subtillis 
[83]—two proteins in the SorC DeoR family that are homologous (similar) in 
structure and function to LsrR, it appears that the steric effects may affect the 
cooperativity between the dimer.   
In cooperative binding, binding of one ligand usually makes the binding of 
other ligands to the same protein more energetically stable. In DNA-protein 
interactions there may be an order to the interactions, if the protein ligand binds to 
multiple DNA sites. In our case, because the O3 mutation has such a strong effect on 
the transcriptional rates and biases in our simulation, we think that the cooperative 
binding of LsrR dimer to the lsr operon at the putative binding sites O1 and O2, and 
O3 and O4 might have ordered priority, with the LsrR dimer binding to sites O3 and 




The phenomenon of “ordered cooperativity” of the system may not natural to 
cooperative binding systems, where a ligand can bind to any unsaturated binding site. 
This may imply that a secondary layer of regulation might be influencing the normal 
randomness of cooperative binding interactions between our ligand (LsrR dimers) and 
our receptor (the putative binding half-sites O3 and O4). Our simulations confirm 
Byrd’s observations that O3 mutations reverses the transcriptional bias of the lsr 
operon , and translate these experimental outputs into computationally relevant 
kinetic parameters that can reflect more than simply the detectable output of the 
system. Byrd had initially suggested that there might have existed an integration host 
factor (IHF) that might specifically recognize the binding half-site O3. IHFs are 
global gene regulators that have been postulated to have a role in the bending of DNA 
[84-87] into different forms. Depending on the series of genes IHF binds to, IHF 
might influence bacterial phenotypes ranging from regulating genes involved with 
bacterial pathogenicity [88] to the growth of flagella in enterohemorrhagic E. coli 
(EHEC)  [85], and may function in gene regulation similar to the role histones play in 
eukaryotic genetic regulation [89-91]. We suggest that if the O3 binding half-site 
contains an interaction point for IHF to influence regulation of the lsr operon, its 
effects can be quantified in kinetic terms by our model.  
This additional layer of regulation that might surround binding site O3 
suggests that the simplistic notion of LsrR as the main quorum sensing “switch” 
might have a small complication. Our mathematical model reflects the potential for 
this small complication, and, as previously discussed, translates these complications 




our system is no longer simply the expression of lacZ (more specifically lacZYA), but 
rather one of 146 genes in E. coli alone responsible for auto-aggregation into 
biofilms, biofilm matrix proteins [80] and invasiveness of S. typhimurium [92]. In this 
context, our simulation work of the lsr intergenic region (and LsrR) as the quorum 
sensing switch provides a simulation framework with which we may not need an 
experimentally-relevant reporter like lacZ to reverse engineer a mechanism for 
biofilm formation involving the lsr quorum sensing system as one part of solving the 
problem of multiple antibiotic resistant infections (and device contaminations). 
Although the proliferation of efflux pumps may present another way to mediate MDR 
directly, no studies have linked any of these efflux pumps, including AcrB in our 
model system (E. coli) to lsrR. And thus, the role of LsrR in MDR might be limited to 
its roles in biofilm formation in E coli.     
The series of simulations we performed to test our model of the lsr quorum 
sensing system may thus be used to study MDR in the context of biofilm formation. 
While we discuss a very basic future applications of this first-principles mode in 
Section 5, these applications can be tied into MDR by providing a simple method 
with which we can assess the presence, quantity, and function of biofilm building 
blocks from bacteria utilizing the lsr quorum sensing system that has been shown, in 
biofilms involving other bacterial species besides E. coli, to increase MDR 1000-
fold[93]. Other models of the lsr quorum sensing system developed by Hooshangi 
and Bentley [43] and Gonzalez Barrios and Achenie [82] address the overall lsr 
quorum sensing system without considering the dynamics of the LsrR quorum 




MDR. Our model incorporates kinetic details of the expression of LsrR, its several 
forms, and tie in the dynamics of those forms of LsrR to an output which can be 
converted to a framework to monitor the kinetics of the lsrR-linked proteins that may 
form the building blocks to one form of MDR. Our parameter search studies also 
present a method by which future modelers can perform virtual mutagenesis 
experiments on ODE systems with a genetic component to estimate changes  on an 
MDR protein or gene of interest. And combining with our use of experimental units 
that can be measured by standard experimental assays, rather than bulk concentration 
measurements, our model presents a platform on which experimenters can predict the 
behavior of network components in their model system that may be accessible via 
experimentation, and allow them to gain more systemic relevance from their 
experiments.  No other model of the lsr quorum sensing system has been able to offer 
such convenience and modeling opportunity to experimenters. And so, besides being 
able to translate the findings of Byrd into a simulation-based context (and providing 
evidence for Gln-33 being the primary binding residue in LsrR to O3 and O1), we 
have done so in a way that experimenters can integrate their own population 










Chapter 5:  Future Work 
 
The model we developed provides a preliminary indication of how LsrR 
quorum sensing might work when we fill in the details of the molecular structures and 
interactions of the many proteins involved in autoinducer-2 quorum sensing systems, 
and in particular, Lsr-based AI-2 quorum systems. We demonstrated our ability to 
model how altering the dynamics of lsr binding regions, as well as the polymeric 
forms of the repressor LsrR might affect expression of genes on either side of the lsr 
operon. However, this work provides a foundation later research that we would like to 
do. This section addresses several of those concerns.  
Section 1: cAMP-CRP Binding Interactions 
One complication we had in constructing our model was our limited 
knowledge of the CRP interactions in our system. Early studies suggest that CRP-
binding interactions not just implicate cAMP-CRP binding in upregulating or 
downregulating transcription of genes on either side of the lsr operon [59,94], but 
they might also be implicated in the folding and unfolding of the lsr operon. Data 
shown in Figure 19, showing the effects of CRP binding site mutations and our 
simulations reflecting the mutations in Figure 26 are shown in Figures 27 and 28, 
reflect the possible effects of mutating the different combinations of CRP binding site 
knockout mutations on expression of the intergenic region. In these cases, we utilized 
CB11 (lsrR knockout strains) whose basal transcription characteristics were similar to 




and B = 1.305). With our putative binding site constants (Kbind|lsrR and Kbind|lsrA) 
and our promoter binding site constants (Vm|lsrR and Vm|lsrA)  set to their base 
values, we estimate our CRP-binding constants kC1 and kC2 using a similar algorithm 
to what we had used to estimate Kbind|lsrR and Kbind|lsrA.  
  
 
Figure 28: Graphical representation of CRP binding site mutations, taken and 













Our early simulation results suggest that we can reflect changes in the CRP binding 
sites in the expression of both sides of the lsr operon, and that there appears to be no 
limit on how low our percent expression (%Exp), defined in Equation 31, can go 
(with 100% expression representing the expression of our positive control (plsrA14 & 
plsrR26). 
   (31) 
This model still does not account for CRP assisting the folding of the lsr operon, as a 
step in reforming the LsrR tetramer in the absence of AI-2. Nor does it necessarily 
involve for any potential integration factors [59,76] that might interact with the lsr 
intergenic region that might assist the DNA in reforming the hairpin loop structure. 
Our work will move towards explaining and modeling the factors necessary in order 
to model this looping process. 
 
Section 2: Promoter Binding Sequences 
Some of our real mutation experiments have also included simulating what happens 
when a mutation occurs not within a putative binding site or CRP binding site, but 
within a promoter binding site. There are two promoter regions that promoters can 
bind to in order to enhance transcription of the lsr operon—sites P1 and P2 shown in 
Figure 19, which sit close to the lsrR and lsrK and lsrACDB genes in the lsr 
operon[59,76]. Since we assumed that a mutation to either promoter region might 
have an influence on expression of the lsr operon in both directions, we incorporated 
this into our model. Rather than having the promoter site mutation directly affect 




the promoter changes through the constants Vm|lsrR and Vm|lsrA, the maximum 
reaction rates of the repression step. If the mutation of the promoter binding site 
downregulates expression in either direction relative to the positive control (plsrA14 
& plsrR26), the mutation is said to increase Vm|lsrR or Vm|lsrA. If the promoter 
binding site mutation turns out to upregulate expression in the same direction (lsrR or 
lsrA) relative to the positive control, then Vm|lsrR or Vm|lsrA decreases relative to the 
positive control value. Experimental results, as well as our simulation results initially 
mentioned in Figure 19 and summarized in Figures 29 and 30 suggest that Vm|lsrR 
and Vm|lsrA do not change in a way that is necessarily consistent, nor is the change in 
expression in the lsrR or lsrA directions very significant.   The sequence of the 
promoter sequence is known, but a clearer picture of other secondary promoters and 
regulators that might affect how the promoter might be expressed is not known, and 
represent a category of simulations that we might want to carry out in the future. 











Figure 31: Simulation results of promoter-site mutations in the lsr intergenic 
region in the lsrA direction. Thesereflecting these effects by modifying Vm|lsrA. 
Simulations were carried out using an algorithm similar to those for determining 












Figure 32: Simulation results of mutation experiments involving promoter-site 
mutations in the lsrR direction.  These mutations were reflected by by modifying 
Vm|lsrR. Simulations were carried out using an algorithm similar to those for 






Section 3: Other modifcations to the Model 
The model we developed offers a simplistic insight into how the structure and 
details of the LsrR repressor may affect the expression of genes on both sides of the 
lsr operon. It is simplistic because we made several assumptions that took out the 
complexities of AI-2 synthesis, potential interactions with other autoinducers, as well 
as AI-2 importation and AI-2 phosphorylation. Below we detail several changes to 
the model that we will make for future studies. 
Subsection 1: Incorporating AI-2 Importation and LsrK Dynamics 
In real Lsr-based quorum systems, AI-2 is imported using an active form of 
Lsr, which we have shown to be synthesized. In the real system, we might expect a 
positive-feedback loop of AI-2 importation and phosphorylation by LsrK leads to the 
synthesis of more Lsr importers, and thus more AI-2 is imported, etc. until the system 
runs out of AI-2. In reality LsrK would not necessarily be the first importer. Some 
studies have identified the phosphoenolpyruvate (PEP)-transferase system (PTS) as 
the initial importer of AI-2 when quorum sensing conditions have been met (AI-2 
concentration above one threshold, bacterial density above another threshold) [66]. 
We will detail the dynamics of the PTS / alternative pathway in internalizing and 
processing AI-2, and the production of LsrK as a protein product in our system. 
However, it is unclear how much of a role the PTS pathway plays once LsrK is in the 
system. These modeling experiments may help to elucidate the role and timing of 
both the PTS pathway, and the LsrK pathway. And in the case of LsrK, we may also 





Subsection 2: Incorporating AI-2 Synthesis 
As previously mentioned in this work, we removed AI-2 synthesis from the 
equation, and simply forced AI-2 curve based on data tracking AI-2 levels in E. coli 
samples, and assumed AI-2 was synthesized elsewhere, and intracellular and 
extracellular AI-2 were in equilibrium with each other, and that the AI-2 
concentration (or population) threshold typically required for bacteria, including E. 
coli, to exhibit population-dependent behavior was already met. The AI-2 synthetic 
pathway is one that is widely conserved and well-elucidated in E. coli [59,76,77,79] 
and other bacterial species [95-100]. We plan on incorporating the synthetic pathway 
in future models. There are several ways we could do this. One way could be to 
simply implement the AI-2 synthetic pathway. But that would also incorporate a 
complication of auto-importation (a cell utilizing AI-2 it had just produced) that we 
could set some basic conditions and determine how auto-importation complicates 
matters. It might be a way to explain why Luo and colleagues separated AI-2 
synthesizers from AI-2 receivers in his AI-2-based microfluidics device [69]. Current 
literature seems to only suggest or implicate the protein TqsA as a chief exporter of 
AI-2. And because AI-2 itself is relatively conserved, there may not be a limit as to 
how much specificity each AI-2 molecule could have. Providing an answer on auto-
importation could help determine whether it is something we need to worry about as 





Subsection 3: Incorporating Our Model Into a Population-Based Model 
While we model quorum-sensing using a constant population, quorum sensing 
in itself is a population-dependent behavior. More often than just cells synthesizing 
lots of AI-2 before importing it back in, quorum sensing mediates responses of groups 
of cells to environmental conditions and mediates a response to those conditions. This 
could mean that, instead of simply mediating the response by the expression of 
reporters of activity of the lsr operon, the output of our model could be the synthesis 
of biofilms, the actuation of antibiotic resistance mechanisms, or swimming in the 
direction of the AI-2—outputs that cannot necessarily be measured by the standard 
beta galactosidase activity assay.  
In future work, we have several different means of incorporating population 
dynamics into our model. Most simply, we could tie our OD600 that we used to 
calculate Miller Units from bulk concentration to the population of bacteria in some 
test volume. The supplemental text in Section 6.2 (Chapter 6, Section 2) provides a 
preliminary method of how we tied OD600 into our calculation, but in the case of our 
model case we assumed an OD600 of 1.0 throughout the entire length of our 
simulation (and in all the simulation data presented in this work). But any vector of 
OD600 data can be used here. And thus, we can tie our model implicitly to population 
growth or death based on definition of the Miller Unit alone.       
To add more complication, we could tie AI-2 synthesis and protein and small 
nucleotide synthesis to population growth. We could implement this simply using a 
Monod model of bacterial growth and substrate consumption, and simply imply 




ATP, and the lsr operon. But that leaves the question of how substrates are reformed, 
because eventually the cultural substrate might run out.  
 
Subsection 4: Simulating the Effects of Inhibitors 
Many efforts have been in place to examine possible quorum sensing 
inhibitors. Much has been made by the use of AI-2 inhibitors and some studies, AI-2 
analogs which can be phosphorylated by LsrK, but cannot de-repress the lsr operon. 
These drugs, which are collectively known as quorum sensing inhibitors (QSIs), show 
promise in treating MDR [60,61]. Our model offers a way in which we could reflect 
the effects of these drugs on expression of both sides of the lsr operon, and 
downstream genes that could convey MDR.  
One such class of drugs may be AI-2 analogs—molecules that are structurally 
similar to AI-2 to bind LsrK [101], but not similar enough to AI-2 to de-repress the 
lsr operon. These molecules could contain the basic DPD structure, but they may 
contain alkyl functional groups (ethyl, propyl, butyl, hexyl) whose hydrophobic 
interactions may not align well with the LBD of LsrR [102], because DPD may not 
cyclize into R/S-DHMF a secondary precursor that must be further hydrated and 
modified in order to form AI-2. With these, so far in vitro, propyl-DPD has 
demonstrated to be an antagonist of the quorum sensing circuit—but it lowers the 
effective kcat from 7.6 s-1 (432 min-1) to 5.8 s-1 (348 min-1), and the effective Km is 
increased from 1.0 mM (1000 µM) to 1.4 mM (1400 µM) [101]. However, IC50, 
which is related to Ki (the inhibition constant for the phosphorylation of DPD (AI-2)) 




implies that propyl-DPD (and other AI-2 analogues) may be competitive inhibitors, 
though this observation has yet to be tested. This seems to suggest that propyl-DPD 
might be a very effective QS inhibitor, which we could represent in our model as a 





Subsection 5: Algorithm Changes 
Even just keeping our model as is, we would like to apply several changes to 
our algorithm to make our estimation algorithm more robust. 
One way, or investigation that we may need to do is reverse the order of Kbind|lsrR 
and Kbind|lsrA calculations. Preliminary results (not shown here) suggest that the 
magnitude of our binding constants do not change because which binding constant to 
calculate first. But this needs to be extended to each experiment to confirm these 
initial findings. 
  One other change may be to fit our model—both in the lsrR direction and the 
lsrA direction (transcription and binding as well) in the same window. In our model, 
we estimated ktcR, B, Kbind|lsrR, and Kbind|lsrA in separate directories (though all under 
the same directory). With ODE23s, the exact value of the output changes with each 
iteration. While the variations are generally <10 Miller Units in this work, it may be 
significant enough that it could throw off Kbind|lsrR and Kbind|lsrA, as well as B. Our 
future work, with this modification, may help us determine how different our 
estimations were, and whether our observations from this study hold up with 
ODE23S actually holding the beta-galactosidase activities constant.  Early prototypes 
geared at automating this process have proven to be computational inefficient in the 
MATLAB language—we see enough that it is possible to streamline our algorithm 






Chapter 6:  Supplementary Material 
 
Supplementary Figure 1: Equations used in our model 
 
Equation # ODE Module 
 
I ((2) in text) 
  
 

























































































































































































Section 1: Cooperative Binding Events 
We assume that the binding of our lsrR dimer to its binding sites on either side 
of the lsrR operon represent the only cooperative binding events in our system. For 
either case, we assume that our reaction series is defined by reaction R2, where nR is 
the cooperativity coefficient defined as by table 2,  is an unstable complex initially 
formed when the dimer reversibly binds to lsrR at binding sites O1 and O2, ε and δ 
are rate constants that govern the forward and reverse reactions at the first step of R2.  
kb is the rate constant governing the binding and stabilization of  to lsrR to form the 
stable species, Db|lsrR (the dimer irreversibly bound to O1/O2).  
                               ε 
   (nR)D + lsrR ======    
 (R2) 
                                    δ 
We now focus on the reversible step, and assume the forward and reverse 
reactions reach rapid equilibrium, and write our balance.  
 
        (3) 
 
We also introduce a new constant, , our association equilibrium constant, as 
defined in (4). 
 
       (4) 
 
We solve (3) for  and utilize our definition in (4) to obtain the expression in (5). 




We now initially consider our second reaction, and write a simple ODE for the 
formation of Db|lsrR and define this expression as our reaction velocity v in (6), where 
kb is defined as in (7). 
     (6) 
        (7) 
 
Vm|lsrR is defined in Table 3, and is the saturation of our free lsrR molecules as 
defined in (8).  
          (8) 
 
We now substitute in the final expression in (5) for  into (8), and simplify (dividing 
out the common lsrR term). 
                (9) 
 
We now define our dissociation constant, KD, in (10)and multiply (9) by (10) to 
obtain our final saturation form in (11).  
      (10) 
     (11) 
 
The expression in (11) represents one form of the Hill equation. However, it 
may be more important for us to find the dissociation constant at which 50% of the 
available binding sites are saturated. We can solve for Kd when = 0.5. We solve 
(11) with this substitution to find out that Kd = DnR. We select the value for our dimer 
concentration D (whatever that value could be for our data), and assign it as Kb|lsrR, 




final expression for our cooperative binding term, kb. Then, we plug (13) back into 
(6) to get our final expression for cooperative binding velocity, which is cooperative 
in relation to our dimer. 
     (12) 
    (13) 





Section 2: Derivation of the Miller Unit-to-Concentration Conversion Factor, κ 
In order for a mathematical model to be relevant for experimenters, the model 
must, in our case, find methods to use the terms and outputs of experimental work. In 
many quorum sensing experiments, this output is usually tied to a change in visual 
output, with some quantification of that visual output, whether in Miller Units, Vibrio 
BB170 assays, or fluorescence imaging. Generally speaking, this requires the 
insertion of a reporter gene, which produces either a fluorophore or a protein that will 
trigger a color-change response to a standard assay.  
For our model, since we are modeling data presented by Byrd et al., we 
represent our experimental data in Miller Units, which is based on early 
investigations of the lac operon by Jeffery Miller and colleagues[103-105].   
Classically, the Miller Unit can be defined as in (15), where A420 and A600 are 
absorbances of our bacterial sample at light wavelengths of 420 Hz and 600 Hz, and 
A550 measures the absorbance of scattered light at 420nm, due to cell debris.   
     (15) 
If we assume that cell debris scattering is negligible in comparison to the direct 
absorption at 420nm, and 600nm, (15) reduces to the form in (16).  
    (16) 
 
In order to proceed from here, we could note that A600 is dependent on the 
bacterial population density. In our model, we assume that if we observe an A600 = 
1.0, we have a cell density of ~109 cells/mL. Likewise, we assume our operating 




change if we want to define our Miller Unit in terms of time in seconds, minutes, or 
hours.   
We must also consider our A420. Our model has been developed in terms of 
bulk concentration µM. But equation (15) and (16) require that we utilize absorbance. 
The Beer-Lambert law, as shown in (17), defines optical density (absorbance) at a 
particular wavelength for a known species as linearly proportional to the bulk molar 
concentration of that species (C). We assume we are carrying out a single 
spectrophotometric experiment, since our indicator, a product of beta-galactosidase 
metabolism, produces a chromophore that emits visible light at a single wavelength. 
      (17) 
 
In (17), Aλ is the optical density (absorbance) of light at a wavelength λ Eλ is an 
extinction coefficient, which we will define here nominally in units of µM-1, and the 
concentration of beta galactosidase produced from our targeted reporter, in µM.   
However, to do our conversion we will need to make a couple further 
assumptions. First, cells fill the entire 1 mL volume of our test system. Second, we 
will assume that a single E. coli cell has a volume of ~1x10-15 L. 
Before we begin the next step in our conversion process, we must convert a 
concentration in terms of molecules/cell to µM (x 10-6 mol/L), as shown below, 
starting off with a concentration of 1 molecule/cell. 
    
 




While we initially define (16) in terms of our concentration by (17), most 
beta-galactosidase manufacturers produce synthetic beta galactosidase will rate their 
beta galactosidase samples by the number of activity units generated per mg beta 
galactosidase. For our model, we selected a beta galactosidase produced by Sigma 
Aldrich that has an activity of 600 activity units (AU) per mg protein, which we will 







Parameter Definition Value Source/Assumed? 




600nm) and cell 
density 
1 x 10-9 cells/mL / 
(1 A600) 
Assumed 
NA Avogadro’s number 1 mol = 6 x 1023 
molecule(s) 
Assumed 






MW Molecular wt. beta-
galactosidase 
125 kDa = 
125,000 mg/mmol 
Assumed 
X Conversion factor 
between 
molecules/E. coli cell 
and bulk 
concentration 
1 molecule/cell = 
0.00167 uM 
This paper 
Vcell Typical volume of E. 
coli cell 
1x10-15 mL Assumed 
Vsample Total sample volume 1 mL Assumed 




Supplementary Figure 3: State variables in this model 
Variable Definition Type Initial Value Source 
 Transporter 
protein Lsr; 






Concentration 0 µM This paper, 
Assumed 
 Autoinducer-2 
(AI-2) outside our 
system 











Concentration 5 µM [106] [107] 
 cAMP binding 
site on lsrR side 





 cAMP binding 
site on lsrA side 





 Cyclic AMP 
(cAMP) 



















Concentration 0 µM This paper, 
Assumed 
 lsrR protein, 
dimer 
Concentration 0 µM This paper, 
Assumed 




Concentration 0 µM This paper, 
Assumed 
 lsrR dimer 
bound to lsrRK 
at O1/O2 
Concentration 0 µM This paper, 
Assumed 
 AI2-P/lsrR dimer 
complex, free 
Concentration 0 µM This paper, 
Assumed 






Concentration 0 µM This paper, 
Assumed 

















































Concentration 0 µM This paper, 
Assumed 




Concentration 0 µM This paper, 
Assumed 




Concentration 0 µM This paper, 
Assumed 














synthesis of lsrR 
monomer 







Parameter Definition Base Value/Units Source 
B Bias to transcribe 
towards lsrACDB 
side of lsr operon 
1.225 (unitless) This thesis, fitted 






binding of the lsrR 
dimer to binding 
sites on lsrACDB 
side of the lsr operon 
(at binding sites O3 
and O4) 





binding of the lsrR 
dimer on lsrRK side 
of lsr operon (at 
binding sites O1 and 
O2) 
1 x 10-4 µM This paper, 
assumed 
 Maximum rate, 
binding of lsrR dimer 
to binding sites O3 
and O4 
1 µM-min-1 This paper, 
assumed 
 Maximum rate, 
binding of lsrR dimer 
to binding sites O1 
and O2 






 Rate constant 
governing binding of 
phosopho-AI2 to 
tetramer, and initial 
cleavage to two 
phosphorylated 
dimers, still bound to 
the lsr operon 






 Rate constant, 
governs the binding 
of cAMP-CRP 
complex to C1 
1 µM-1-min-1 This paper, 
assumed 
 Rate constant, 
governs the binding 
of cAMP-CRP 
complex to C2 
1 µM-1-min-1 This paper, 
assumed 
 Rate constant 
governing the binding 
of cAMP to CRP 
1 µM-1-min-1 This paper, 
assumed 




1 min-1 This paper, 
assumed 




1 min-1 This paper, 
assumed 




1 min-1 This paper, 
assumed 
 Rate constant; 
specific degradation 
of phosphor-AI2 
1 min-1 This paper, 
assumed 
 Rate constant; 
specific degradation 
of free lsrR dimer  
1 min-1 This paper, 
assumed 
 Rate constant; 
specific degradation 
of lsrR monomer 
1 min-1 This paper, 
assumed 
 Rate constant; 1 min











 Rate constant; AI-2 
phosphorylation by 
lsrK 
1   This paper, 
assumed 
 Rate constant; 
dimerization of lsrR 
monomer 
1 µM-1-min-1 This paper, 
assumed 
 Rate constant; 
breakdown of cAMP-
CRP complexes 
bound to lsr operon to 
cAMP and CRP 






 Rate constant; 
maximum 





Defined by B*ktcR This paper, 
defined by model 
 Rate constant; 
maximum 
transcription rate of 
mRNA of lsrRK as 
defined by our model 
+ associated 
reporter/lacZ 
2.1 min-1 This paper, fitted 
to Figure 3.6b 
from [59] 
 Rate constant; 
governing the 
formation of the lsrR 
tetramer 




of dimer to O3/O4 




of dimer to O1/O2 
1.4 This paper, 
assumed 
α AI-2 curve fitting 
parameter; Controls 
the peak height of the 
AI-2 curve 
0.005 µM (800 
Activity Units) 
This paper, fitted 
β AI-2 curve fitting 
parameter; Peak 
height location; offset 
from t =0 





γ AI-2 curve fitting 
parameter; Parameter 
controlling peak 
width of AI-2 curve 
110 min This paper, fitted 
Ψ Conversion factor; 
molecules/cell to µM 
concentration 
See paper  This paper, 
converted 
κ Conversion factor to 
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